Title: Acute Renal Failure
1Acute Renal Failure
- Du Juan
- Department of Nephrology
- Renmin Hospital of Wuhan University
2Definitions
- Acute Renal Failure (ARF) is a syndrome
characterized by rapid (hours to weeks) decline
in glomerular filtration rate (GFR) and retention
of nitrogenous waste products such as creatinine
3Definitions
- Clinical Syndrome
- Abrupt Sustained Decline in GFR
- Occurs over Hours or Days
- Rising Serum Creatinine(44.2µmol/L /day)
- Clinical Results
4Definition of AKI
- Functional or structural abnormalities or
- markers of kidney damage including
- abnormalities in blood , urine or tissue
tests - or imaging studies present forlt3 months
5???????
- ??????????3????????????,???????????????????????
?
6Criteria for AKI
- 48???Scr??26.5µmol/L(0.3mg/dl)
- ?????50
- ????,lt0.5ml/kg/h ,??6????(????????????)
7Staging of AKI
Phase Scr Criteria Urine Output Criteria
1 ?0.3mg/dl or?50 lt0.5ml/kg/h6hr
2 ?200-300 lt0.5ml/kg/h12hr
3 ?300 Oliguria 4.0mg/dl (lt0.3ml/kg/h24hr ) (Acute rise0.5mg/dl ) or Anuria12hr
8Classification
9Prerenal ARF (1)
Intravascular Volume Depletion
Hemorrage
Gastrointestinal Losses
Renal Losses
Skin and Mucous Losses
10Prerenal ARF (2)
11Postrenal ARF
Bilateral Ureteric Obstruction
Bladder Neck Obstruction
Urethral Obstruction
12Intrarenal ARF (1)
Diseases of Glomeruli
13Intrarenal ARF (2)
Tubulointerstitial Nephritis
Renal Biopsy
Rash
Fever
Hematuria
14Intrarenal ARF (3)
Diseases of Large Renal Vessels
Thrombosis
Atheroembolism
15Intrarenal ARF (4)
Acute Tubular Necrosis(ATN)
16(No Transcript)
17 18ATN
- Etiology
- Pathogenisis
- Pathology
- Clinical Presentations
- Laboratory Examinations
- Diagnosis Differentiation
- Management
19Etiology
Ischemic ATN
Severe or prolonged renal hypoperfusion
Nephrotoxic ATN
Many medications and poisons
20Pathogenesis
21????
- ????????
- ???????,???????
- ?????(Intratubular Obstruction)
- ?????(Tubular Fluid Backleak)
- ???????????
22Ischemic / Toxic Renal Injury
Tubular Damage
Hemodynamic Abnormalities
Endothelial Swelling Reduced EDRF Vasoconstrictor
Release Endothelin Angiotensin Thromboxane Norepin
ephrine
? Tubuloglomerular Feedback
Afferent Arteriolar Constriction
Tubular Obstruction
Backleak
?Kf
? Glomerular Capillary Pressure
? RBF
Reduced Glomerular Filtration Rate
23Events Following the Initiation of Renal Ischemia
Renal Ischemia
? Supply of O2 Nutrients to Kidney
ATP ?
Nephrotoxins ? Lipid Peroxidation
? Oxygen-Derived Free Radicals ? Scavenging
Systems ?
Tubular Sodium PumpIinhibition Na, Cl- ? pH
? Cell Volume
Abnormal Metabolic Levels Adenosine
? Hypoxanthine ?
Cell structure changes Membrane
Integrity Cytoskeleton Damaged Mitochondria Swell
Pathologic Changes Tubular Dysfunction Leakage,
Obstruction, Loss of Filtration,
Necrosis Intrarenal Vessel Constriction
Increased Ischemia Cell death
24Pathology
25 26Tubule vacuolization (green arrow)
Tubule dilation and brush border losses
(black arrows)
Mild ATN
27Severe ATN
Denuded basement membrane and the presence of
intraluminal casts
- Degenerated and sloughed,
- frank necrosis tubular cells
28Clinical Course of ATN
- Initiation Phase
- Maintenance Phase
- Recovery Phase
29????
30Initiation Phase
- Reversible Fall in GFR Preventive
- Hypotension
- Sepsis
- Renal Toxins
31Maintenance Phase
- Oliguria Phase
- 714d or Even 46w of Duration
- OliguriaUrine Outputlt400ml/d
- AnuriaUrine Outputlt100ml/d
- Nonoliguria
32Clinical Presentations (1)
- Disturbance of Water?Electrolyte Base- Acid
Homeostasis - Hyponatremia(????)
- Hyperkalemia(????)
- Hypocalcemia (????)
- Hyperphosphatemia(????)
- Metabolic Acidosis(??????)
33Clinical Presentations (2)
- Systemic Complications Infection
- The most common and serious
- complications of ARF
- Occurring in 50 to 90 of cases
- Aaccouting for up to 75 of deaths
34Clinical Presentations (3)
- Systemic Complications
- Gastrointestinal Symptoms Anorexia, Nausea,
Vomiting, Hemorrhage - Cardiac Complications Hypertension, Congestive
Heart Failure, Arrhythmias -
35Clinical Presentations (4)
- Pulmanary Complications Infection, Adult
Respiratory Distress Syndrome - ?????????ARDS
- Neruopsychiatric Disturbance Confusion, Delirium
or Coma, Seizure - ??????????????? ??
36Recovery Phase
- Volume of Urine
- 3000-5000ml/d Duration 1-3w
- Complications
- Hyponatremia?Hypokalemia
- Infection
- Redecreased Volume of Urine
- Renal Biopsy Show Everlasting Renal Pathological
Changes in Minority of Patients
37Laboratory Examinations
- Blood Analysis
- Urinalysis
- Imaging Evaluation
- Renal Biopsy
38 Blood-Rt and BCA
- Serum Creatinine BUN?
- Serum Potassium ?
- Serum Sodium ?
- Serum Calcium ?
- Serum HCO3- ?
- Mild-Moderate Anemia
- Serum BUN/Scr
39Urinalysis
- Urine Output ????????????
- Urine Sediment ???????
- Urine Specific Gravity ???lt1.015
- Urine Osmotality ?????lt350mOsmol/L
- Urinary Na Concentration ??2060mmol/L
- Urinary Creatinine/Plasma Creatinine Ratio
-
???/???lt20
40Renal Tubular Epithelial Cell Casts
41- Imaging Investigations
- Ultrasound B?
- Plain Abdomen ????
- Excretory Urography/Cystourethrography
- ???????/??????
- CT Scanning
- Isotope Renography or Renal Angiography
- ?????????
- Renal Biopsy
42Diagnosis
- History
- Abrupt Sustained Decline in Renal Function
- Increased Absolute Scr 44.2umol/L/d
- Increased Relative Scr 25 Over Baseline/d
- Clinical Manifestations
- Laboratory Examinations
43Differential Diagnosis
- ARF Secondary to CKD
- Prerenal ARF
- Postrenal ARF
- Intrinsic ARF
44Postrenal ARF
- Primary Disease of Urinary Obstruction
- Abrupt Oliguria or Even Anuria
- Renal Angina
- Tenderness or Percussion
- Signs of Urine Retention
- Renal Imaging
45Prerenal ARF
- Transfusion Test
- History of Body Fluids Losses
- Signs of Hypovolemia
- IV.drop 5 Glucose 200250ml IV. Frusemide
40100mg -
-
46Differential Diagnosis Between Pre-renal ARF and
ATN
Diagnosis Index Prerenal ARF ATN
Urine Gravity gt1.018 lt1.015
Urine Osmotality(mmol/L) gt500 lt350
Urine Natrium Concentration (mmol/L) lt20 gt20
Serum BUN/Scr gt20 lt15
ARF Index lt1 gt1
Natrium Filtration Fraction lt1 gt1
Urine Sediment Clarity Cast Brown Granular Casts
Transfusion Test -
47 Treatment (1)
- Prevention(??????,??????)
- Identify at Risk Patients(??????)
- Pre-existing CKD, Diabetes, Elderly
- Optimise Renal Perfusion
- IV Fluids, Blood Transfusion
- Avoid Nephrotoxic Agents
- NSAIDS, Radiocontrast, Aminoglycosides,ACEI
- Maintain Adequate Diuresis?
- Frusemide
48 Treatment ( 2 )
- Management of Volume Homeostasis
- Record I/O
- Fluid Urine Output 500ml
- Diuretics
- Dialysis
49 Treatment (3)
- Management of Electrolyte Homeostais
- Hyponatremia
- Hyperkalemia
- Hypocalcemia
- Hyperphosphatemia
50(No Transcript)
51Methods of Treatment
DURATION 30 minutes 1 - 4 hours 1 - 8 hours
DOSE 10 ml of 10 50 ml of 50 10U 100ml200ml
of 5
DRUG Calcium Glucose Glucose Insulin Natrium
Bicarbonate Na polysterne sulfonate Dialysis
There is always dialysis!
52 Treatment (4)
- Nutritional Support
- Calorie 35Kcal/kg/d
- Maximal Carbohydrate and Lipid
- Minimal Recommand Protein Intake 0.8g/kg/day
- Limit Na?K?Cl Intake
- IV. Essence Amino Acid
53 Treatment (5)
- Heart Failure
- Digoxine
- Diuretics
- Vessel Dilative Agents
- Dialysis Most Effective
- Infection
-
54 Treatment (6)
- Absolute Indications
- Volume Overload
- Hyperkalemia
- Metabolic Acidosis
- Overt Uremic Symptoms
-
-
55- Prophylaxis Dialysis
- Relieve Retention of Excess Water and Toxins
- Maintain Electrolyte and Acid-Base Homeostais
- For Nutritional Therapy
- Avoid MOSD
56Dialysis Pattern
- Intermittent Hemodialysis(IHD)
- Continuous Renal Replacement Therapy
- Peritoneal Dialysis(PD)
57?????
- ?????
- ???? 6.5mmol/L??
- BUN21.4mmol/L?Scr442umol/L
- ???????
- ??BUN??8.9mmol/L?Scr??176.8umol/L,????1mmol/
L
58- ??2????4???
- ??? CO2CPlt13mmol/L, pHlt7.25
- ??2?????????????
- ???? ????? ??gt6.0mmol/L,????????
59??????
- ?????
- ????????????
- ??????
- ???????
- ???????
- ?????????
60Prognosis
- ATN Without Complications 7-23
- ATN With MOSD 50-80
-
61Questions
- Whats the Difference between Acute Renal Failure
and ATN? - How to Deal with Hyperkalemia in ARF Patients?
- What is the Indication of Hemodialysis in ARF
Patients?
62 THANK YOU